Management and in-hospital mortality of 2235 patients with a traumatic intimal tear of the thoracic aorta - Jacob-Brassard J, Al-Omran M, Nathens AB, Forbes TL, De Mestral C.
OBJECTIVE: Our goal was to describe contemporary management and in-hospital mortality associated with blunt thoracic aortic intimal tears (IT) within the American College of Surgeons Trauma Quality Improvement Program. SUMMARY BACKGROUND DATA: The evid... (Source: SafetyLit)
Source: SafetyLit - September 7, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Heart rhythm disorders are best managed when patients are listened to
(European Society of Cardiology) Atrial fibrillation is the most common heart rhythm disorder and increases the risk of stroke by fivefold. Patients with irregular heartbeats should choose the treatment plan with their health professionals, according to European Society of Cardiology (ESC) Guidelines published online today in European Heart Journal, and on the ESC website. The document was developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2020 Category: International Medicine & Public Health Source Type: news

Cardiology compensation continues to rise; new interventional measures reported
(American College of Cardiology) MedAxiom, an American College of Cardiology Company and the premier source for cardiovascular organizational performance solutions, has released its eighth annual Cardiovascular Provider Compensation and Production Survey. The report reveals trends across cardiology, surgery, advanced practice providers (APPs) and non-clinical compensation that help cardiovascular organizations as they face a new normal and are reevaluating compensation models and the definition of work productivity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2020 Category: International Medicine & Public Health Source Type: news

Hitting the nail on the head: overcoming therapeutic resistance in lung cancer
(Medical University of South Carolina) An interdisciplinary team at the Medical University of South Carolina has shown that Neuropilin 2, a protein highly expressed in lung cancer cells, is a critical player in conferring resistance to targeted therapy in lung cancer. Their findings are reported in an article published in The Journal of Thoracic and Cardiovascular Surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 24, 2020 Category: Cancer & Oncology Source Type: news

What Are the Main Acyanotic Congenital Heart Diseases?
Discussion Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here. Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also. Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Mesothelioma Clinical Trials Resume After COVID-19 Disruption
When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen in the United States, more treatment centers are resuming mesothelioma study activities and ramping up enrollment. Clinical research trials offer patients access to experimental mesothelioma treatments that haven’t yet been approved by the U.S. Food and Drug Administration. These treatments may provide higher chances of survival than the current standard of care. “So far, every patient I have seen during the COVID-19 pande...
Source: Asbestos and Mesothelioma News - August 10, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Study Shows Peritoneal Mesothelioma Surgery Underutilized
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a third of those diagnosed with peritoneal mesothelioma are undergoing potentially curative cytoreductive mesothelioma surgery, according to a comprehensive study of the National Cancer Database by researchers at Inova Fairfax Medical Center in Virginia. Annals of Surgical Oncology published the mesothelioma study earlier this year. “Patients who have the surgery perform much better than those who do not. Ye...
Source: Asbestos and Mesothelioma News - July 28, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Quitline plus surgery are big motivators for giving up smoking
(University of California - Davis Health) Smokers who have thoracic surgery are much more likely to stop using tobacco if they also complete a quitline intervention, a new UC Davis Health study shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 28, 2020 Category: International Medicine & Public Health Source Type: news

Thorough Risk Assessment Essential Prior to Noncardiac Surgery
MONDAY, July 27, 2020 -- Comprehensive preoperative assessment of cardiovascular risk with history and physical examination is essential prior to noncardiac surgery, according to a review published in the July 21 issue of the Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2020 Category: Pharmaceuticals Source Type: news

Phase III data show Roche ’s Port Delivery System with ranibizumab enabled over 98% of patients to go six months between treatments for neovascular age-related macular degeneration
Basel, 22 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced detailed results from the phase III Archway study evaluating its investigational Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD), a leading cause of blindness globally.1 In Archway, 98.4% of PDS patients were able to go six months without needing additional treatment and achieved vision outcomes equivalent to patients receiving monthly ranibizumab eye injections, a current standard of care. In the study, PDS was generally well-tolerated, with a favourable benefit...
Source: Roche Media News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Phase III data show Roche ’s Port Delivery System with ranibizumab enabled over 98% of patients to go six months between treatments for neovascular age-related macular degeneration
Basel, 22 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced detailed results from the phase III Archway study evaluating its investigational Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD), a leading cause of blindness globally.1 In Archway, 98.4% of PDS patients were able to go six months without needing additional treatment and achieved vision outcomes equivalent to patients receiving monthly ranibizumab eye injections, a current standard of care. In the study, PDS was generally well-tolerated, with a favourable benefit...
Source: Roche Investor Update - July 22, 2020 Category: Pharmaceuticals Source Type: news

Commercially Viable Mobile Lung Screening Program Feasible
TUESDAY, July 14, 2020 -- Developing a commercially viable and financially sound mobile program for lung screening is feasible, according to a study published online July 14 in the Annals of Thoracic Surgery. James R. Headrick Jr., M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Lung screening bus brings high-tech health care directly to patients
(The Society of Thoracic Surgeons) A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 14, 2020 Category: Cancer & Oncology Source Type: news

Latissimus Dorsi Flap for Thoracic Wall Defects Latissimus Dorsi Flap for Thoracic Wall Defects
Is this technique a safe and effective reconstructive option for post-sternotomy thoracic wall defects?ePlasty, Open Access Journal of Plastic Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2020 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

Association of trauma center level and patient volume with outcomes for penetrating thoracic trauma - Checchi KD, Calvo RY, Badiee J, Rooney AS, Sise CB, Sise MJ, Bansal V, Martin MJ.
BACKGROUND: We investigated the potential link between trauma center American College of Surgeons verification level and institutional volume of penetrating thoracic trauma with outcomes for patients with penetrating thoracic trauma. METHODS: Penetrating... (Source: SafetyLit)
Source: SafetyLit - July 6, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Cryoablation Study for Mesothelioma Opening at UCLA
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The pilot study will measure immune system stimulation through local tumor infiltration in hopes of extending patient survival in the future. Cryoablation, also known as cryotherapy or cryosurgery, freezes localized tumors with liquid nitrogen or argon gas. It has been proven effective in killing tumor cells with extreme cold. It is currently used on kidney, liver and prostate cancers, but its use in priming a person’s own i...
Source: Asbestos and Mesothelioma News - July 1, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

What Causes Bradycardia?
Discussion Bradycardia is a heart rate below what the lowest value that is normal for age. Infants and children have higher heart rates that slowly decrease with age to adult levels. It is usually noted as an incidental finding because of increased vagal tone. Reasons for cardiology referral include associated heart murmur, syncope especially if associated with exercise or unusual triggers, other signs such as chest pain or palpitations, family history of sudden cardiac death, congenital heart disease or familial heart disease, bradycardic medication use, or unusual symptoms associated with the concern. Severe bradycardia ...
Source: PediatricEducation.org - June 22, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

What Causes Free Peritoneal Fluid?
Discussion Peritoneal fluid is normal. It decreases the friction of the peritoneum covering abdominal and pelvic organs and helps to protect them and allow their movement. A normal amount of peritoneal fluid is expected on radiological evaluation. Increased peritoneal fluid is a continuum and is concerning as a wide variety of pathological causes are associated with it such as abdominal trauma and appendicitis. At the far end of the scale is ascites that is the accumulation of free fluid more than 25 ml. It is usually associated with abdominal distension but fluid must accumulate before distension can occur and therefore i...
Source: PediatricEducation.org - June 8, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Healthy People Shouldn ’ t Take Daily Aspirin To Prevent Heart Disease, Review Finds
(CNN) — Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review. Aspirin is still one of the most commonly used medications in the world, even though it’s no longer recommended as a preventative by many health authorities. There is no evidence that low-dose aspirin — less than 325 milligrams a day — should be taken by most adults in good cardiovascular health, according to a new review of existing research that published Wednesday in the British Journal of Clinical Pharmacology. The review, which focused on the risks and benefits of low-dose d...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news

Combat thoracic surgery in Iraq and Afghanistan: 2002-2016 - Stern CA, Stockinger CZT, Gurney LJM.
This study examines thoracic surgical workload in Iraq and Afghanistan to help define surgical... (Source: SafetyLit)
Source: SafetyLit - June 1, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Google Search Trends Show Elective Surgery Is Still Down, But Improving
As more U.S. states begin to resume elective surgeries, hospitals and medical device companies have a strong financial incentive to see procedure volumes return to normal. The tough part, however, is convincing patients that it's safe to have them done now. In the first of what is expected to be a weekly report, Needham & Co.'s medtech analyst, Mike Matson, said he is tracking elective surgery searches using Google Trends to gauge the recovery pace of elective procedure volume in the United States. Matson noted that Google searches for 20 different types of el...
Source: MDDI - May 21, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

Lungs of deceased COVID-19 patients show distinctive features
(Brigham and Women's Hospital) In a new study in the New England Journal of Medicine (NEJM), senior author, Steven J. Mentzer, MD, thoracic surgeon at Brigham and Women's Hospital, and a team of international researchers examined seven lungs obtained during autopsy from patients who died of COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 21, 2020 Category: Infectious Diseases Source Type: news

Tissue level implants in healthy versus medically compromised patients. A cohort comparative study.
CONCLUSIONS:In terms of Success, Failure and Survival rates, tissue level implants placed in Healthy and in Medically compromised individuals showed no short-term (1 year) differences. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 20, 2020 Category: Dentistry Source Type: news

Procedure Recovery May Be Slower than Expected, Survey Says
A consumer survey conducted by analysts at Needham & Co. sheds some light onto what the procedure recovery could look like in the United States as hospitals in many states have begun resuming elective procedures. "The results of the survey indicate that consumers remain hesitant about elective procedures with 26% indicating that they don't feel comfortable having an elective procedure until 2021 or later," said Mike Matson, a medtech analyst at Needham & Co. The firm surveyed 269 consumers across the United States on May 11 and May 12, however the analysts noted that the number of responses va...
Source: MDDI - May 15, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business COVID-19 Source Type: news

High Career Satisfaction Reported by Many Thoracic Surgeons
But 55.7 percent of cardiothoracic surgeons who responded report symptoms of burnout or depression (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 14, 2020 Category: Respiratory Medicine Tags: Cardiology, Pulmonology, Surgery, Journal, Source Type: news

High Career Satisfaction Reported by Many Thoracic Surgeons
THURSDAY, May 14, 2020 -- Thoracic surgeons have high career satisfaction, but more than half report symptoms of burnout and depression, according to a study published online May 14 in the Annals of Thoracic Surgery. John S. Ikonomidis, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2020 Category: Pharmaceuticals Source Type: news

Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation
IRVINE, CA – May 8, 2020 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH® SF Ablation Catheter, evaluated in the PRECEPT study for the treatment of persistent atrial fibrillation (AF), resulted in freedom from any documented, symptomatic atrial arrhythmias at 15 months post-procedure for eight out of ten study participants (80.4 percent).1 Use of the THERMOCOOL SMARTTOUCH SF CATHETER for persistent atrial fibrillation is investigational only. This PRECEPT study data support a Premarket Approval supplement application to the U.S. Fo...
Source: Johnson and Johnson - May 12, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Predicting outcomes of penetrating cardiovascular injuries at a rural center by different scoring systems - Arikan AA, Sel çuk E, Bayraktar FA.
OBJECTIVE: To compare the anatomical and physiological scoring systems and the outcomes of surgical management of penetrating cardiovascular trauma at a rural center. METHODS: Seventy-seven patients underwent emergency surgery at our center between... (Source: SafetyLit)
Source: SafetyLit - May 11, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

How the Coronavirus Is Helping to Fix China ’s Broken Healthcare System
When Dai Yufan began developing a fever and painful cyst, her first thought was to see a doctor. But due to the COVID-19 pandemic, visiting her local hospital seemed scarier than her symptoms. “So I tried an online health service,” says Dai, 27, an office worker in the southern Chinese city of Shenzhen. “I asked about my condition via an app and [a doctor online] suggested some medicine and other treatments.” While the coronavirus has stretched medical services around the world to breaking point, the virus has also fostered a boom in online medical services, known as telehealth. The industry is pred...
Source: TIME: Health - May 6, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Mesothelioma Drug Combination Continues to Show Promise
Pharmaceutical giant Bristol Myers Squibb continues to tout its immunotherapy combination of Opdivo and Yervoy for first-line treatment of patients with pleural mesothelioma cancer. Bristol Myers Squibb recently announced that overall survival “significantly improved” when the combination was measured against standard chemotherapy in a randomized, phase III clinical trial of previously untreated mesothelioma patients. Its announcement was based on a pre-specific interim analysis conducted by the Data Monitoring Committee, a clinical study organization independent of Bristol Myers Squibb. The study is being cond...
Source: Asbestos and Mesothelioma News - May 4, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Why patients with lung cancer in a COVID-19 era need to keep their treatment
Patients with cancer are at a higher risk of having a more severe COVID-19 illness. "Unfortunately, COVID-19 has severely affected those who are diagnosed with lung cancer," says Dr. Shanda Blackmon, a thoracic surgeon at Mayo Clinic. "We know that these patients who get infected with COVID-19 while they're immune compromised are increasingly susceptible to having a worse [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 30, 2020 Category: Databases & Libraries Source Type: news

U.S. FDA Approves IMBRUVICA ® (ibrutinib) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
HORSHAM, Pa., April 21, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with rituximab for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who are new to therapy. The approval is based on positive results from the landmark Phase 3 E1912 study that was designed and conducted by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and sponsored by the National Cancer Institute, part of the National Institutes of Health. Today’s mi...
Source: Johnson and Johnson - April 22, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

UK Oncologist Proposes Novel Treatment for Mesothelioma
Medical oncologist Dr. Angus Dalgleish never did like standard of care treatment for pleural mesothelioma cancer, even when he reluctantly recommended it in the past. He believes now there is something better. Dalgleish, of St. George’s Hospital, University of London, recently published a case report detailing a novel treatment regimen that turned a six-month life expectancy for one patient into a six-year survival. The treatment involved a series of anti-inflammatories that included low-dose naltrexone, vitamin D3 supplements and the vaccine IMM-101, which heightens a patient’s own immune response. “Init...
Source: Asbestos and Mesothelioma News - April 22, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Smokers, Vapers in Special Danger From Coronavirus
MONDAY, April 20, 2020 -- Smokers and vapers who get COVID-19 are more likely to have complications, so this might be a good time to quit, the Society of Thoracic Surgeons says. An early study from China looked at 78 hospitalized COVID-19 patients.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 20, 2020 Category: General Medicine Source Type: news

COVID-19 Business Updates Provide Some Clarity
The unknowns still outnumber the knowns, but recent business updates provide some clarity around how the medical device industry is fairing during the COVID-19 pandemic. First and foremost, it is clear that companies are hurting in the areas of elective procedures, which are being deferred. But there may be some silver linings hidden amongst the bad news. Needham & Co. medtech analyst Mike Matson estimates that medical device sales across the industry will continue to drop by an average of 40% to 50% until the economy begins to reopen and hospitals start to resume elective procedures. Matson's e...
Source: MDDI - April 10, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

How Common are Congenital Rib Abnormalities?
Discussion The embryonic mesoderm forms the skeletal system. The mesoderm is further divided into the dorsal, sclerotome and ventral dermatome. The sclerotome forms the ribs which are under the influence of various genes and growth factors. Congenital rib abnormalities occur in number ( the normal 12 ribs) or in formation/structural. Malformations can include hypoplastic, bridging, forked, fused and hypoplastic ribs. Even ribs with holes occur because of the segmentation issues. Illustrated examples can be found here. The rib’s cartilage, bone or both can be affected. Location along the rib is also variable. Abnormal...
Source: PediatricEducation.org - April 6, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefi...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mesothelioma Survivors Face Critical COVID-19 Challenges
As the U.S. comes to grips with the challenges of the COVID-19 pandemic, mesothelioma cancer survivors face additional hurdles, including difficulty receiving care. Patients currently undergoing treatment for cancer and those who are immunocompromised are at greater risk of serious health issues if they contract COVID-19, according to the Centers for Disease Control and Prevention. “Cancer patients are a high-risk group and should be extra vigilant in terms of isolation precautions. They should follow the medical authorities’ instructions,” Dr. Ory Wiesel, a thoracic surgeon at Maimonides Medical Center ...
Source: Asbestos and Mesothelioma News - March 26, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

What Causes Tachycardia?
Discussion Tachycardia is a rapid heart rate that is above normal for age and level of exertion. Tachycardia is common, particularly sinus tachycardia due to normally encountered circumstances such as pain, fever or exercise. It is usually a normal physiologic process but sustained tachycardia often indicates a potentially abnormal underlying cause. Sinus tachycardia has a rapid heart rate with normal P waves and P-R intervals and variations from moment to moment and respiration. Generally it is not over 200 beats/minute. Vagal stimulation can slow the heart rate; this is a gradual slowing, not an abrupt slowing seen in ...
Source: PediatricEducation.org - March 23, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

Bariatric Surgery Tied to Lower Long-Term Risk for Major CV Events
THURSDAY, March 19, 2020 -- For patients with obesity, bariatric surgery is associated with a lower long-term risk for major cardiovascular events and incident heart failure, according to a study published online March 18 in the European Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2020 Category: Pharmaceuticals Source Type: news

Frailty may be highly predictive of complications, death in patients with mitral valve disease
(The Society of Thoracic Surgeons) Frailty measurements have become increasingly important in assessing surgical risk in patients with mitral valve disease, and research published online today in The Annals of Thoracic Surgery shows that frailty plays a significant role in outcomes following mitral valve procedures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2020 Category: International Medicine & Public Health Source Type: news

Coronavirus Postpones Mesothelioma Symposium
The Mesothelioma Applied Research Foundation has postponed its annual International Symposium on Malignant Mesothelioma next month because of the COVID-19 virus, commonly known as the novel coronavirus. The event is the largest gathering of the mesothelioma community each year. It was scheduled for April 6-7 in San Antonio, Texas. Officials with the Mesothelioma Applied Research Foundation announced the postponement Wednesday but has not yet rescheduled. Each year, the symposium brings together patients, caregivers, advocates, attorneys, financial consultants, doctors and nurses from various disciplines. The goal is to edu...
Source: Asbestos and Mesothelioma News - March 5, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study to Clarify Radiation Benefits in Mesothelioma Patients
An upcoming phase III clinical trial involving the National Cancer Institute should clarify the still-debatable benefits of using radiotherapy in combination with aggressive surgery for patients with pleural mesothelioma. The trial will be the first multicenter, randomized study measuring both safety and potential survival benefits of intensity-modulated radiation therapy (IMRT) and pencil-beam scanning with pleurectomy and decortication surgery and chemotherapy. The trial is sponsored by NRG Oncology and will involve several mesothelioma specialty centers across the country. The goal is to enroll a combined 150 patients. ...
Source: Asbestos and Mesothelioma News - March 3, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery
Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will measure the safety and efficacy of using two different immunotherapy drug regimens — Opdivo (nivolumab) and Yervoy (ipilimumab) — beginning 42 days before surgery. The hope is that at least one will make surgical resection more effective. Sidney Kimmel Cancer Center at Johns Hopkins University, MD Anderson Cancer Center at the University of Texas and Greenebaum Cancer Center at the University of Maryland are working together to enroll a...
Source: Asbestos and Mesothelioma News - February 24, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Abbott ’s Coronary Dilation Catheters Face Class I Recall
Abbott Laboratories is facing a Class I Recall of its coronary dilation catheters. The Abbott Park, IL-based company said that “certain lots” of the NC Trek RX Coronary Dilatation Catheter would be impacted by the recall. According to FDA’s website the firm field personnel and Affiliates directly contacted the first customers beyond the firm's control via phone, email, or personal visit to facilitate rapid notification, Jan. 29, 2020. The "URGENT MEDICAL DEVICE RECALL" Notification informed customers that specific lots of its Coronary Dilatation Catheters with...
Source: MDDI - February 20, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

A Look at Specialty Polymers for Surgical Robots
The surgical robot industry is developing specialized products for neurosurgery, spinal surgery and other medical procedures that require greater precision, flexibility, and control than is possible with conventional techniques. Today, more than 5,000 surgical robots are installed worldwide – and that market is expected to grow at a double-digit rate over the next few years. For the designers of surgical robots, this presents both challenges and opportunities. The healthcare industry has discovered the numerous advantages of robotic surgery. For example, surgeons can benefit from having a higher viewing a...
Source: MDDI - February 19, 2020 Category: Medical Devices Authors: Anna Maria Bertasa Tags: Materials Assembly and Automation Source Type: news

Abbott Wins Approval for CATALYST Trial for At-Risk Stroke Patients
This study is an extremely important step in assessing the Amplatzer Amulet as an effective non-prescription drug alternative for patients with AFib who are at an increased risk for ischemic stroke." In an email sent to MD+DI, Abbott wrote, “We already have an Amulet IDE trial underway that is intended to support our submission for approval in the U.S. for Amplatzer Amulet. The newly announced CATALYST trial will support our submission for an expanded indication for Amulet as a safe and effective alternative to NOAC drugs for patients with atrial fibrillation and at risk of stroke.”...
Source: MDDI - February 3, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

Using innovative research to drive new opportunities for lung treatments
In 1998, the year that Larry Page and Sergey Brin incorporated Google in Silicon Valley, Dr. Gerard Criner was working with a small team of biomedical engineers in a basement outside of San Francisco. The engineers and Criner, founding chair of the Department of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, were trying to develop tools they hoped would transform the treatment of certain lung diseases. For decades, flexible fiber optic bronchoscopy was the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2020 Category: Pharmaceuticals Authors: Temple Health Source Type: news

Using innovative research to drive new opportunities for lung treatments
In 1998, the year that Larry Page and Sergey Brin incorporated Google in Silicon Valley, Dr. Gerard Criner was working with a small team of biomedical engineers in a basement outside of San Francisco. The engineers and Criner, founding chair of the Department of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, were trying to develop tools they hoped would transform the treatment of certain lung diseases. For decades, flexible fiber optic bronchoscopy was the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 1, 2020 Category: Biotechnology Authors: Temple Health Source Type: news